S&T Bank’s Encompass Health EHC Stock Holding History

S&T Bank’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$3.18K	–	440
2025 Q3	$3.18K	Buy	+25	New	+$2.98K	﹤0.01%	361

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

S&T Bank's EHC Position: Q4 2025 in Review

S&T Bank sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 25 shares — an estimated $3.18K sold.

S&T Bank first reported a position in EHC in Q3 2025 and held it in 1 quarter. The position peaked at $3.18K in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

S&T Bank reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
S&T Bank sold 25 Encompass Health shares in Q4 2025, an estimated $3.18K.
S&T Bank first reported a position in Encompass Health in Q3 2025 and held it in 1 quarter.
S&T Bank's Encompass Health position peaked at $3.18K in Q3 2025.
594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on S&T Bank's 13F filing for Q4 2025, filed 13 Feb 2026.